iSBTc 22nd Annual Meeting

Annual Meeting Main Page   |   Award Winners   |   Download Final Program
CME Information   |   Documents & News Releases   |   Presentation Slides & Schedule
Faculty   |   Pictures   |   Download Abstracts

November 2 - 4, 2007
Seaport World Trade Center
Boston, Massachusetts

Sunday Presentations
Slides for select presentations below have been provided by the corresponding speaker for your convenience.
Please click the next to the speaker's name for the slides you wish to view.

Schedule at a Glance  |  Presentations  |  Friday Presentations  |  Saturday Presentations  |  Sunday Presentations

Sunday, November 4
8:00 am - 8:45 am	Update: 2006 Mini-Symposium Update Chair: George Coukos, MD, PhD - University of Pennsylvania Medical Center Speaker: Michael B. Atkins, MD - Beth Israel Deaconess Medical Center
8:30 am - 8:45 am	Update: National Cancer Institute Immunotherapy Agent Workshop Martin A. Cheever, MD - Fred Hutchinson Cancer Research Center
8:45 am - 11:00 am	Plenary Session: Vaccines / Dendritic Cells Co-Chair: Mary L. Disis, MD - University of Washington Lothar H. Finke, MD - ARGOS Therapeutics
8:45 am - 9:15 am	The Development of Provenge® (Sipuleucel-T) an Active Cellular Immunotherapy for Prostate Cancer David L. Urdal, PhD - Dendreon Corporation
9:15 am - 9:30 am	Long-Term Survival in Patients with Metastatic Melanoma Vaccinated with Melanoma-Antigen Loaded Dendritic Cells Joseph W. Fay, MD - Baylor University Medical Center
9:30 am - 9:45 am	Phase II Trial of a 10-Epitope CTL Vaccine, IDM-2101, in Metastatic NSCLC Patients: Induction of Immune Responses and Clinical Efficacy Minal Barve, MD - Mary Crowley Cancer Research Centers
9:45 am - 10:00 am	Different DC Populations Interact with Memory & Effector T Cells, or with Treg Cells Pawel Kalinski, MD, PhD - University of Pittsburgh Cancer Institute
10:00 am - 10:15 am	Features of Lympoid Neogenesis After Dermal Injection of Incomplete Freund’s Adjuvant with or without Peptides Craig L. Slingluff, Jr., MD - University of Virginia
10:15 am - 10:30 am	IMA901, a Novel Multi-Peptide Vaccine for the Treatment of Renal Cell Carcinoma - Pre-Clinical and Clinical Studies and Implications for Combination with Other Agents Harpreet Singh, PhD - Immatics Biotechnologies GmbH
10:30 am - 11:00 am	Insulin like Growth Factor Receptor Family Members: Essential Tumor Antigens in Breast Cancer Mary L. Disis, MD - University of Washington
11:00 am - 11:15 am	Refreshment Break
11:15 am - 12:45 pm	Hot Topic Sessions: Vaccines / Dendritic Cells Moderators: Bernard A. Fox, PhD - Earle A. Chiles Research Institute Jon M. Wigginton, MD - Merck & Co., Inc. Participants: Brent A. Blumenstein, PhD - TriArc Consulting Lee S. Simon, MD - Beth Israel Deaconess Medical Center Charles Drake, MD, PhD - Johns Hopkins University David L. Urdal, PhD - Dendreon Corporation James W. Young, MD - Memorial Sloan-Kettering Cancer Center
12:45 pm	Meeting Adjourns

All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.